Prices delayed by at least 15 minutes | Print
Hemogenyx Pharmaceuticals PLC (HEMO)
ORD GBP0.01Open
1.638p
Previous close
1.6p
Trade high
1.6879p
Volume
12,610,160
Year high
7.13p
Year low
1.10p
Dividend yield
-
Market capitalisation
£22.42 mn
P/E ratio
-
ISIN
GB00BYX3WZ24
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Hemogenyx Pharmaceuticals PLC is a operator of a biotechnology company intended to focus on the discovery, development, and commercialization of novel therapies and treatments for blood diseases, like leukaemia and lymphoma. The company's technologies aim to change the way in which bone marrow/hematopoietic stem cell transplants are performed and improve their efficacy, its three distinct products include an immunotherapy product for the treatment of relapsed/refractory acute myeloid leukaemia (AML) and patient conditioning, the bi-specific antibody, for the treatment of AML and a community-based rehabilitation / Biomedical engineering platform, enabling users to generate treatments for existing and emerging viral infections.
News
Recent trades
Date | Time | Price | Quantity | Value (£) |
---|---|---|---|---|
18/04/2024 | 04:42:57 | 1.6075 | 1,000,000 | 16,075.00 |
18/04/2024 | 04:24:11 | 1.6879 | 68,662 | 1,158.95 |
18/04/2024 | 04:22:34 | 1.643 | 231,657 | 3,806.12 |
18/04/2024 | 04:22:34 | 1.65 | 229,526 | 3,787.18 |
18/04/2024 | 04:20:47 | 1.6739 | 416 | 6.96 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.